Myopia Control Drops | OSRX Pharmaceuticals

Myopia Control Drops

Studies show that a low dose of atropine, typically administered as eye drops in the evening, has the potential to significantly slow the progression of myopia in children – helping prevent severe nearsightedness.¹

To make caring for children's vision simpler, OSRX offers three low-dose atropine drops. We now compound 0.01%, 0.025% and 0.05% concentrations, allowing you to customize myopia treatment by patient. Our OMNI atropine eye drops ship directly to your patients or practice (your choice) at no added cost.

How to Prescribe: New prescribers must complete an OSRX account form. Once completed, a member of our staff will contact you to discuss pricing, ordering options and shipping details.

Questions? Check out our FAQ.

Atropine Sulfate 0.01%
Sterile Ophthalmic Solution

3.5 mL

Atropine Sulfate 0.025%
Sterile Ophthalmic Solution

3.5 mL

Atropine Sulfate 0.05%
Sterile Ophthalmic Solution

3.5 mL

"I've found the low dose atropine formulations from OSRX to be an excellent adjunct to my myopia management arsenal ... my patients are happy with the price and convenience of direct shipments to their homes. I would highly recommend OSRX for all your practice's compounding needs."
- DR. ROBERT GEROWITZ, OD, FIAO

"OSRX is easy to work with and provides top-of-the-line drops. Since we brought Atropine therapy into our practice for myopia control, they've made it both affordable and easy to get ... I highly recommend OSRX for all of your compounding pharmacy needs."
- DR. BRIANNA RHUE, OD, WEST BROWARD EYECARE ASSOCIATES

"Since recently launching our low-dose atropine program for myopia control, I've already prescribed OSRX's drops to many of my patients as adjunct therapy with Ortho-K and stand-alone therapy for myopia control. Due to the low concentration, patients rarely experience any side effects typical of atropine in higher concentrations. I truly believe prescribing atropine drops to myopic children has become the standard of care."
- DR. DENNIS LEUNG, OD, GOLDEN VISION OPTOMETRY

¹Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2, Chia, Audrey et al., Ophthalmology, Volume 123, Issue 2, 391 – 399

²Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019;126(1):113-124. doi:10.1016/j.ophtha.2018.05.029